|
WDR82 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.34680000002585E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.383890E-03 |
| Normal-vs-Stage2 |
1.753990E-04 |
| Normal-vs-Stage3 |
3.47169999970198E-07 |
| Normal-vs-Stage4 |
1.970810E-04 |
| Stage1-vs-Stage2 |
1.567600E-01 |
| Stage1-vs-Stage3 |
6.801900E-03 |
| Stage1-vs-Stage4 |
1.056200E-01 |
| Stage2-vs-Stage3 |
5.538200E-01 |
| Stage2-vs-Stage4 |
9.829400E-01 |
| Stage3-vs-Stage4 |
5.581800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.60399999996164E-06 |
| Normal-vs-AfricanAmerican |
6.561900E-03 |
| Normal-vs-Asian |
5.781200E-01 |
| Caucasian-vs-AfricanAmerican |
8.906200E-01 |
| Caucasian-vs-Asian |
5.635900E-02 |
| AfricanAmerican-vs-Asian |
1.198590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.61928999999894E-05 |
| Normal-vs-Female |
1.614390E-04 |
| Male-vs-Female |
8.577600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.483970E-01 |
| Normal-vs-Age(41-60Yrs) |
4.445000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.80734999999377E-05 |
| Normal-vs-Age(81-100Yrs) |
4.88059999970147E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.506600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.994200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.147530E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.210400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.143100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.365600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.542800E-01 |
| Normal-vs-Grade 2 |
1.622010E-03 |
| Normal-vs-Grade 3 |
8.08969999877007E-08 |
| Normal-vs-Grade 4 |
1.995170E-03 |
| Grade 1-vs-Grade 2 |
2.010000E-01 |
| Grade 1-vs-Grade 3 |
1.149940E-02 |
| Grade 1-vs-Grade 4 |
1.292830E-01 |
| Grade 2-vs-Grade 3 |
3.563600E-03 |
| Grade 2-vs-Grade 4 |
3.202400E-01 |
| Grade 3-vs-Grade 4 |
3.674800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.88352999999086E-05 |
| Normal-vs-ccB subtype |
7.315100E-03 |
| ccA subtype-vs-ccB subtype |
2.458200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.03349999999825E-05 |
| Normal-vs-N1 |
3.582400E-01 |
| N0-vs-N1 |
6.508400E-01 |
|
|
